T cell leukemia control via Ras-Raf pathway inhibition with peptides

RATIONALE: RAS-RAF-MEK-ERK pathway has been considered a promising target for anticancer therapy. However, tumor cells may develop resistance against such drugs via hyperactivation of N-Ras, which explains why novel therapeut-ic approaches. In this sense, the Institute Curie- Université Pierre et Ma...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marín, Gustavo Horacio, Bruzzoni Giovanelli, H., Schinella, Guillermo Raúl
Formato: Articulo
Lenguaje:Inglés
Publicado: 2017
Materias:
Ciencias Médicas
peptides
cancer
leukemia
mice
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/78709
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652266/
Aporte de:
SEDICI (UNLP) de Universidad Nacional de La Plata

Ejemplares similares

Ejemplares similares